ArticleMovement disorders clinical practice2025
Natural History and Progression of Dentatorubral-Pallidoluysian Atrophy (DRPLA): A Retrospective Study of 22 Patients.
Article in Movement disorders clinical practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Update on Genetic Chorea.Current neurology and neuroscience reports · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDentatorubral-pallidoluysian atrophy (DRPLA) is a rare neurodegenerative disorder and exhibits diverse clinical phenotypes depending on the age at disease onset. Motor and swallowing functions gradually deteriorate as the disease progresses.
objectiveThis study aimed to evaluate natural history and progression of DRPLA.
methodsWe retrospectively analyzed patients with DRPLA (n = 22; juvenile-onset: 9, adult-onset: 13), investigating their age at disease onset and the associated clinical features. We determined the age at the beginning of gait disturbance, wheelchair requirement, and bedridden state as motor milestones, in addition to the age at the initiation of enteral nutrition.
resultsThe mean ages at disease onset were 12.4 and 36.7 years in juvenile- and adult-onset groups, respectively. Overall, epilepsy and myoclonus were observed more frequently in the juvenile-onset than in the adult-onset group, whereas choreoathetosis and psychiatric symptoms exhibited the opposite trend. Ataxia and cognitive impairment were observed in all patients. Additionally, median intervals from the onset of gait disturbance to wheelchair requirement and to bedridden state were 3.0 and 9.0 years in juvenile-onset group compared to 7.0 and 12.0 years in the adult-onset group. Enteral nutrition was administered to 17 patients (77.3%) and the age of initiation almost coincided with the age at which patients became bedridden.
conclusionsOur analysis showed that the duration from wheelchair requirement to becoming bedridden was approximately 5 years in these two groups despite their different phenotypes, with several factors likely contributing to this outcome. Our findings help predict disease progression for patients and their families.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.